Negative effect of leptin on bone mass in type 1 diabetes

Hania Kassem, Asma Arabi, Mira S. Zantout, Sami T. Azar

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Studies investigating the effect of leptin on bone mass were inconsistent and some related it to the effect of insulin. We intend in this cross-sectional study to investigate the effect of leptin on bone mass in type 1 diabetic patients. We recruited 42 patients with type 1 diabetes for which we determined weight, height, HbA1c, microalbuminuria, serum leptin, bone mineral content (BMC) and density (BMD), and body composition. The patients had an average age of 20.1 ± 0.6 years, an average body mass index (BMI) of 23.6 ± 0.5 kg/cm2 and an average duration of diabetes of 9.1 ± 1.0 years. The Z-score was not correlated with HbA1c or duration of the disease, and the average Z-score was not different in patients with microalbuminuria as compared to patients with no reported microalbuminuria. On the other hand, Z-score and BMC correlated negatively with leptin (r = -0.31; p = 0.04 and -0.60, p < 0.01, respectively). These correlations persisted after adjustment for fat mass. We conclude that not metabolic control of diabetes, but serum leptin has a negative effect on bone density in young patients with type 1 diabetes. This negative effect of leptin on bone density maybe, in part, due to deficiency of endogenous insulin secretion in these patients.

Original languageEnglish (US)
Pages (from-to)237-241
Number of pages5
JournalActa Diabetologica
Volume45
Issue number4
DOIs
StatePublished - Dec 2008
Externally publishedYes

Fingerprint

Leptin
Type 1 Diabetes Mellitus
Bone Density
Bone and Bones
Insulin
Body Composition
Serum
Body Mass Index
Cross-Sectional Studies
Fats
Weights and Measures

Keywords

  • Bone
  • Bone mineral density
  • Leptin
  • Osteoporosis
  • Type 1 diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Negative effect of leptin on bone mass in type 1 diabetes. / Kassem, Hania; Arabi, Asma; Zantout, Mira S.; Azar, Sami T.

In: Acta Diabetologica, Vol. 45, No. 4, 12.2008, p. 237-241.

Research output: Contribution to journalArticle

Kassem, Hania ; Arabi, Asma ; Zantout, Mira S. ; Azar, Sami T. / Negative effect of leptin on bone mass in type 1 diabetes. In: Acta Diabetologica. 2008 ; Vol. 45, No. 4. pp. 237-241.
@article{4087d2d2cd064b8da9066175727c9baa,
title = "Negative effect of leptin on bone mass in type 1 diabetes",
abstract = "Studies investigating the effect of leptin on bone mass were inconsistent and some related it to the effect of insulin. We intend in this cross-sectional study to investigate the effect of leptin on bone mass in type 1 diabetic patients. We recruited 42 patients with type 1 diabetes for which we determined weight, height, HbA1c, microalbuminuria, serum leptin, bone mineral content (BMC) and density (BMD), and body composition. The patients had an average age of 20.1 ± 0.6 years, an average body mass index (BMI) of 23.6 ± 0.5 kg/cm2 and an average duration of diabetes of 9.1 ± 1.0 years. The Z-score was not correlated with HbA1c or duration of the disease, and the average Z-score was not different in patients with microalbuminuria as compared to patients with no reported microalbuminuria. On the other hand, Z-score and BMC correlated negatively with leptin (r = -0.31; p = 0.04 and -0.60, p < 0.01, respectively). These correlations persisted after adjustment for fat mass. We conclude that not metabolic control of diabetes, but serum leptin has a negative effect on bone density in young patients with type 1 diabetes. This negative effect of leptin on bone density maybe, in part, due to deficiency of endogenous insulin secretion in these patients.",
keywords = "Bone, Bone mineral density, Leptin, Osteoporosis, Type 1 diabetes",
author = "Hania Kassem and Asma Arabi and Zantout, {Mira S.} and Azar, {Sami T.}",
year = "2008",
month = "12",
doi = "10.1007/s00592-008-0050-y",
language = "English (US)",
volume = "45",
pages = "237--241",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia",
number = "4",

}

TY - JOUR

T1 - Negative effect of leptin on bone mass in type 1 diabetes

AU - Kassem, Hania

AU - Arabi, Asma

AU - Zantout, Mira S.

AU - Azar, Sami T.

PY - 2008/12

Y1 - 2008/12

N2 - Studies investigating the effect of leptin on bone mass were inconsistent and some related it to the effect of insulin. We intend in this cross-sectional study to investigate the effect of leptin on bone mass in type 1 diabetic patients. We recruited 42 patients with type 1 diabetes for which we determined weight, height, HbA1c, microalbuminuria, serum leptin, bone mineral content (BMC) and density (BMD), and body composition. The patients had an average age of 20.1 ± 0.6 years, an average body mass index (BMI) of 23.6 ± 0.5 kg/cm2 and an average duration of diabetes of 9.1 ± 1.0 years. The Z-score was not correlated with HbA1c or duration of the disease, and the average Z-score was not different in patients with microalbuminuria as compared to patients with no reported microalbuminuria. On the other hand, Z-score and BMC correlated negatively with leptin (r = -0.31; p = 0.04 and -0.60, p < 0.01, respectively). These correlations persisted after adjustment for fat mass. We conclude that not metabolic control of diabetes, but serum leptin has a negative effect on bone density in young patients with type 1 diabetes. This negative effect of leptin on bone density maybe, in part, due to deficiency of endogenous insulin secretion in these patients.

AB - Studies investigating the effect of leptin on bone mass were inconsistent and some related it to the effect of insulin. We intend in this cross-sectional study to investigate the effect of leptin on bone mass in type 1 diabetic patients. We recruited 42 patients with type 1 diabetes for which we determined weight, height, HbA1c, microalbuminuria, serum leptin, bone mineral content (BMC) and density (BMD), and body composition. The patients had an average age of 20.1 ± 0.6 years, an average body mass index (BMI) of 23.6 ± 0.5 kg/cm2 and an average duration of diabetes of 9.1 ± 1.0 years. The Z-score was not correlated with HbA1c or duration of the disease, and the average Z-score was not different in patients with microalbuminuria as compared to patients with no reported microalbuminuria. On the other hand, Z-score and BMC correlated negatively with leptin (r = -0.31; p = 0.04 and -0.60, p < 0.01, respectively). These correlations persisted after adjustment for fat mass. We conclude that not metabolic control of diabetes, but serum leptin has a negative effect on bone density in young patients with type 1 diabetes. This negative effect of leptin on bone density maybe, in part, due to deficiency of endogenous insulin secretion in these patients.

KW - Bone

KW - Bone mineral density

KW - Leptin

KW - Osteoporosis

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=55949108685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55949108685&partnerID=8YFLogxK

U2 - 10.1007/s00592-008-0050-y

DO - 10.1007/s00592-008-0050-y

M3 - Article

C2 - 18690407

AN - SCOPUS:55949108685

VL - 45

SP - 237

EP - 241

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 4

ER -